Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

ZY

Zymergen (ZY)

Zymergen Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ZY
FechaHoraFuenteTítuloSímboloCompañía
31/10/202215:49Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ZYZymergen Inc
21/10/202215:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ZYZymergen Inc
21/10/202215:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZYZymergen Inc
19/10/202211:36Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ZYZymergen Inc
19/10/202211:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ZYZymergen Inc
19/10/202208:08PR Newswire (US)Ginkgo Bioworks Completes Acquisition of ZymergenNASDAQ:ZYZymergen Inc
19/10/202207:23Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ZYZymergen Inc
12/10/202206:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ZYZymergen Inc
12/10/202206:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZYZymergen Inc
25/07/202206:01PR Newswire (US)Ginkgo to Acquire ZymergenNASDAQ:ZYZymergen Inc
14/07/202215:56GlobeNewswire Inc.Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery PlatformNASDAQ:ZYZymergen Inc
28/06/202215:05GlobeNewswire Inc.Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing ApplicationsNASDAQ:ZYZymergen Inc
08/06/202205:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ZYZymergen Inc
31/05/202206:28Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:ZYZymergen Inc
26/05/202215:05GlobeNewswire Inc.Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery PlatformNASDAQ:ZYZymergen Inc
24/05/202207:30GlobeNewswire Inc.Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)NASDAQ:ZYZymergen Inc
13/05/202205:13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ZYZymergen Inc
12/05/202216:30Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZYZymergen Inc
12/05/202215:05GlobeNewswire Inc.Zymergen Reports Preliminary First Quarter 2022 Financial ResultsNASDAQ:ZYZymergen Inc
29/04/202207:00GlobeNewswire Inc.Zymergen to Participate in the BofA Securities 2022 Healthcare ConferenceNASDAQ:ZYZymergen Inc
20/04/202216:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZYZymergen Inc
13/04/202215:05GlobeNewswire Inc.Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022NASDAQ:ZYZymergen Inc
22/03/202215:05GlobeNewswire Inc.Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:ZYZymergen Inc
16/03/202215:05GlobeNewswire Inc.Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022NASDAQ:ZYZymergen Inc
06/03/202218:00GlobeNewswire Inc.Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further TestingNASDAQ:ZYZymergen Inc
28/02/202207:00GlobeNewswire Inc.Zymergen to Present at the 42nd Annual Cowen Healthcare ConferenceNASDAQ:ZYZymergen Inc
14/02/202214:23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ZYZymergen Inc
10/01/202219:17GlobeNewswire Inc.Zymergen Debuts Automation Business and Shares Program Portfolio at 40th Annual JP Morgan Healthcare ConferenceNASDAQ:ZYZymergen Inc
09/01/202220:00GlobeNewswire Inc.Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology PlatformNASDAQ:ZYZymergen Inc
05/01/202215:05GlobeNewswire Inc.Zymergen to Present at the 40th Annual J.P. Morgan Healthcare ConferenceNASDAQ:ZYZymergen Inc
 Showing the most relevant articles for your search:NASDAQ:ZY

Su Consulta Reciente